|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 07:00 03-May-2013 | CLIN | Holding(s) in Company | RNS | +11.40% |
| 09:58 02-May-2013 | CLIN | Director/PDMR Shareholding | RNS | +10.96% |
| 07:00 29-Apr-2013 | CLIN | New £20m banking facility | RNS | +5.16% |
| 07:00 05-Apr-2013 | CLIN | Holding(s) in Company | RNS | +1.40% |
| 07:20 26-Mar-2013 | CLIN | Clinigen Group plc acquires oncology support therapy Cardioxane for US$33 million | BZN | +5.68% |
| 07:00 11-Mar-2013 | CLIN | Clinigen Group and Theravance Entered into Exclusive Commercialization Agreement in the EU for Antibacterial VIBATIV® | BZN | -2.79% |
| 07:00 27-Feb-2013 | CLIN | Interim results | RNS | +10.46% |
| 15:35 14-Feb-2013 | CLIN | Holding(s) in Company | RNS | +2.12% |
| 15:34 14-Feb-2013 | CLIN | Holding(s) in Company | RNS | +2.12% |
| 15:32 14-Feb-2013 | CLIN | Holding(s) in Company | RNS | +2.12% |
| 07:00 31-Jan-2013 | CLIN | Notice of Interim Results | RNS | -0.58% |
| 07:00 24-Jan-2013 | CLIN | Annual Report and accounts | RNS | +0.10% |
| 10:38 21-Dec-2012 | CLIN | Holding(s) in Company | RNS | +2.88% |
| 10:10 22-Nov-2012 | CLIN | Holding(s) in Company | RNS | +0.20% |
| 07:00 11-Oct-2012 | CLIN | Exercise of over-allotment option | RNS | +0.05% |
| 09:20 27-Sep-2012 | CLIN | Notification of major interest in shares | RNS | +6.99% |
| 11:01 26-Sep-2012 | CLIN | Director's Share Dealing | RNS | +5.85% |
| 07:15 25-Sep-2012 | CLIN | Stabilisation Notice | RNS | +4.03% |
| 07:00 25-Sep-2012 | CLIN | First day of dealings | RNS | +4.03% |
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds